Cocrystal Pharma Receives Investment Through Private Placement

BOTHELL, WA and ATLANTA, GA (Marketwired Apr 24, 2017) On April 20, 2017, Cocrystal Pharma, Inc. (OTCQB: COCP) (the Company ) closed on proceeds of $3,000,000 in a private placement offering (the Offering ) of 12,500,000 shares of the Company s common stock at a purchase price of $0.24 per share. The purchasers included one of the members of the Company s board of directors, Chairman Dr. Raymond F. Schinazi. In addition, OPKO Health, Inc. invested in the Offering, of which the Company s
http://bit.ly/2oFFhTh